MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Mantle cell lymphoma

(UMLS:C4721414)

UMLS ID:: C4721414
MeSH ID:: D020522

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.386.480.525

Classification 2:

Name:

Hemic and Lymphatic Diseases
MeSH Tree Number(s):: C15.604.515.569.480.525

Classification 3:

Name:

Immune System Diseases
MeSH Tree Number(s):: C20.683.515.761.480.525

Synonym(s)

Mantle cell lymphoma

Classical Mantle Cell Lymphoma

Mantle Cell Lymphoma

Mantle Zone Lymphoma

cell lymphoma mantle

lymphoma, mantle cell

lymphoma; mantle zone

mantle cell lymphoma

mantle cell lymphomas

10.

mantle zone; lymphoma

11.

mantle-cell lymphoma

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Lenalidomide	FAERS: 139	US FAERS
2	PCI 32765	FAERS: 26 Canada Vigilance: 11	Canada Vigilance US FAERS
3	venetoclax	FAERS: 13	US FAERS
4	temsirolimus	FAERS: 9	US FAERS
5	Bortezomib	FAERS: 8	SIDER US FAERS
6	Thalidomide	FAERS: 7	OFFSIDES US FAERS
7	Methotrexate	FAERS: 5	US FAERS
8	idelalisib	FAERS: 4	US FAERS
9	Clopidogrel	FAERS: 3	US FAERS
10	Imatinib Mesylate	FAERS: 3	US FAERS
11	Sunitinib	FAERS: 3	OFFSIDES US FAERS
12	carbidopa, levodopa drug combination	FAERS: 3	US FAERS
13	Bendamustine Hydrochloride	FAERS: 2	US FAERS
14	Deferasirox	FAERS: 2	US FAERS
15	Ifosfamide	FAERS: 2	OFFSIDES US FAERS
16	Teriparatide	FAERS: 2	US FAERS
17	eltrombopag	FAERS: 2	US FAERS
18	tofacitinib	FAERS: 2	US FAERS
19	Alendronate	FAERS: 1	US FAERS
20	Azacitidine	FAERS: 1	US FAERS
21	Clozapine	FAERS: 1	US FAERS
22	Fingolimod Hydrochloride	FAERS: 1 Canada Vigilance: 2	Canada Vigilance US FAERS
23	Imatinib Mesylate	FAERS: 1	US FAERS
24	Imiquimod	FAERS: 1	US FAERS
25	Lamotrigine	FAERS: 1	US FAERS
26	Liraglutide	FAERS: 1	US FAERS
27	Mesna	FAERS: 1	US FAERS
28	Metformin	FAERS: 1	US FAERS
29	Methotrexate	FAERS: 1	US FAERS
30	Omeprazole	FAERS: 1	US FAERS
31	Oxymetazoline	FAERS: 1	US FAERS
32	Pentostatin	FAERS: 1	US FAERS
33	Phenelzine	FAERS: 1	US FAERS
34	Prednisone	FAERS: 1	US FAERS
35	Pyridostigmine Bromide	FAERS: 1	US FAERS
36	Ranolazine	FAERS: 1	US FAERS
37	Roflumilast	FAERS: 1 Canada Vigilance: 1	Canada Vigilance US FAERS
38	Ruxolitinib phosphate	FAERS: 1	US FAERS
39	Sildenafil Citrate	FAERS: 1	US FAERS
40	Tiotropium Bromide	FAERS: 1	US FAERS
41	Valsartan	FAERS: 1 Canada Vigilance: 2	Canada Vigilance US FAERS
42	apixaban	FAERS: 1	US FAERS
43	Cytarabine		OFFSIDES
44	Etoposide		OFFSIDES
45	Fluorouracil		OFFSIDES
46	Maraviroc		OFFSIDES
47	Morphine		OFFSIDES
48	Phenprocoumon		OFFSIDES
49	Prednisolone		OFFSIDES
50	Pregabalin		OFFSIDES
51	Pyridostigmine Bromide		OFFSIDES
52	fludarabine phosphate		OFFSIDES
53	fludarabine		OFFSIDES
54	pilsicainide		OFFSIDES
55	telithromycin		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Lymphoma, Follicular	48.9%
2	T-Cell Lymphoma	48.9%
3	Sezary Syndrome	37.1%
4	Lymphoma, T-Cell, Cutaneous	36.5%
5	Lymphoma, AIDS-Related	36.5%
6	Enteropathy-Associated T-Cell Lymphoma	36.5%
7	Primary Effusion Lymphoma	36.5%
8	Hodgkin Disease	35.5%
9	Composite Lymphoma	34.7%
10	Lymphomatoid Granulomatosis	34.1%
11	Mycosis Fungoides	30.3%
12	Lymphomatoid Papulosis	30.3%
13	Plasmablastic lymphoma	30.3%
14	Burkitt Lymphoma	27.6%
15	Tumor Lysis Syndrome	22.7%
16	Autoimmune Lymphoproliferative Syndrome	18.8%
17	Lymphoma, Extranodal NK-T-Cell	17.9%
18	Infectious Mononucleosis	17.4%
19	Plasmacytoma	17.2%
20	Primary amyloidosis	15.8%
21	Lymphangioleiomyomatosis	15.1%
22	Histiocytic Disorders, Malignant	14.8%
23	Leukemia, T-Cell	14.4%
24	Leukemia, B-Cell	14.4%
25	Heavy Chain Disease	14.3%
26	Sarcoidosis	14.1%
27	Leukemia, Plasma Cell	13.7%
28	Agammaglobulinemia	13.5%
29	Waldenstrom Macroglobulinemia	13.4%
30	Multiple Myeloma	13.4%
31	Lymphocele	12.3%
32	leukemia	12.3%
33	Neoplasms, Germ Cell and Embryonal	12.3%
34	Neoplasms, Glandular and Epithelial	12.3%
35	Germ Cell Cancer	12.3%
36	Neuroectodermal Tumors	11.7%
37	Granuloma	11.5%
38	Neoplasms, Neuroepithelial	11.3%
39	Gliomatosis cerebri	11.3%
40	Adenitis	11.1%
41	Histiocytosis	11.1%
42	Lymphadenitis	11.1%
43	Lymphangitis	11.1%
44	Lymphedema	11.1%
45	Splenic Diseases	11.1%
46	Thymus Hyperplasia	11.1%
47	Pseudolymphoma	11.1%
48	Lymphadenopathy	11.1%
49	Thymus Neoplasms	10.9%
50	Paraproteinemias	10.5%
51	Thymoma	10%
52	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	9.8%
53	Leukemia, Large Granular Lymphocytic	9.8%
54	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	9.8%
55	Carcinosarcoma	9.7%
56	Hemangiosarcoma	9.7%
57	lymphangiosarcoma	9.7%
58	melanoma	9.6%
59	Meningioma	9%
60	Lymphatic Abnormalities	9%
61	Transfusion Reaction	8.9%
62	Hypotensive Transfusion Reaction	8.9%
63	Hypergammaglobulinemia	8.9%
64	Malignant histiocytosis	8.7%
65	Histiocytic sarcoma	8.7%
66	Medulloblastoma	8.5%
67	Carcinoma 256, Walker	8.4%
68	Monoclonal Gammopathy of Undetermined Significance	8.3%
69	Splenic Neoplasms	8.2%
70	Lymphangiectasis, Intestinal	8.2%
71	Adenoma, Acidophil	8%
72	Ganglioneuroma	8%
73	Glioma	8%
74	Malignant Glioma	8%
75	Basal cell carcinoma	7.7%
76	Carcinoma, Papillary	7.7%
77	Squamous cell carcinoma	7.7%
78	Chondrosarcoma	7.7%
79	Craniopharyngioma	7.7%
80	Cystadenoma	7.7%
81	leiomyosarcoma	7.7%
82	liposarcoma	7.7%
83	Mesothelioma	7.7%
84	synovial sarcoma	7.7%
85	Trophoblastic Neoplasms	7.7%
86	Neuroectodermal Tumor, Melanotic	7.7%
87	Angiomyolipoma	7.7%
88	Clear Cell Sarcoma of Soft Tissue	7.7%
89	Alveolar Soft Part Sarcoma	7.7%
90	Neuroendocrine Tumors	7.7%
91	Sarcoma, Myeloid	7.7%
92	Carcinoma, Basal Cell	7.7%
93	Leukemia, Experimental	7.7%
94	Hamartoma	7.6%
95	Neoplasms, Hormone-Dependent	7.6%
96	Neoplasms, Multiple Primary	7.6%
97	Paraneoplastic Syndromes	7.6%
98	Precancerous Conditions	7.6%
99	Neoplasms, Second Primary	7.6%
100	Melanoma, Experimental	7.5%
101	Mucocutaneous Lymph Node Syndrome	7.4%
102	Adenoma	7.3%
103	Ameloblastoma	7.3%
104	Angiokeratoma	7.3%
105	Carcinoma	7.3%
106	Chordoma	7.3%
107	Hemangioma	7.3%
108	hemangiopericytoma	7.3%
109	Lymphangioma	7.3%
110	Mesenchymoma	7.3%
111	Nevus	7.3%
112	Teratoma	7.3%
113	Hepatoblastoma	7.3%
114	Mixed Tumor, Mullerian	7.3%
115	Germinoma	7.3%
116	Teratocarcinoma	7.3%
117	Angiofibroma	7.3%
118	Sarcoma	7.3%
119	Epithelioma	7.3%
120	Autoimmune Diseases	7.2%
121	Hypersensitivity	7.2%
122	Immunologic Deficiency Syndromes	7.2%
123	Immune reconstitution syndrome	7.2%
124	Immune Reconstitution Inflammatory Syndrome	7.2%
125	Carcinoma, Ehrlich Tumor	7.2%
126	Dermoid Cyst	7.2%
127	Carcinoma, Lewis Lung	7.2%
128	Carcinoid Tumor	7.2%
129	Neurilemmoma	7.2%
130	Hutchinson's Melanotic Freckle	7.2%
131	Melanoma, Amelanotic	7.2%
132	Sarcoidosis, Pulmonary	6.8%
133	Cystadenocarcinoma	6.7%
134	Fibrosarcoma	6.7%
135	Osteosarcoma	6.7%
136	Mucoepidermoid Carcinoma	6.7%
137	Leukemia, Radiation-Induced	6.6%
138	Astrocytoma	6.3%
139	Ependymoma	6.3%
140	oligodendroglioma	6.3%
141	Ganglioglioma	6.3%
142	gliosarcoma	6.3%
143	Anaplastic astrocytoma	6.3%
144	Anaplastic Oligodendroglioma	6.3%
145	Hematologic Neoplasms	6.3%
146	Adenofibroma	6.2%
147	Fibroadenoma	6.2%
148	Malignant Fibrous Histiocytoma	6.2%
149	Choriocarcinoma	6.2%
150	Carcinoma, Lobular	6.2%
151	Cyst	6.2%
152	Neoplastic Processes	6.2%
153	Neoplastic Syndromes, Hereditary	6.2%
154	Pregnancy Complications, Neoplastic	6.2%
155	Endometrial Stromal Sarcoma	6.2%
156	Neoplasms, Experimental	6.1%
157	Elephantiasis	6%
158	Hypersplenism	6%
159	Elephantiasis Nostras Verrucosa	6%
160	Sarcoma, Experimental	6%
161	Malignant Carcinoid Syndrome	5.9%
162	Leukemia L1210	5.8%
163	Leukemia P388	5.8%
164	Acanthoma	5.8%
165	Bowen's Disease	5.7%
166	Paraganglioma	5.7%
167	Rhabdomyosarcoma	5.7%
168	Giant Cell Tumor of Bone	5.7%
169	Glioblastoma	5.5%
170	Neuroblastoma	5.5%
171	Glioblastoma Multiforme	5.5%
172	Retinoblastoma	5.5%
173	Multiple Endocrine Neoplasia	5.5%
174	Dermatofibrosarcoma	5.2%
175	Dermatofibrosarcoma Protuberans	5.2%
176	Ganglioneuroblastoma	5.1%
177	Neoplasms, Radiation-Induced	5.1%
178	Neurofibrosarcoma	5.1%
179	Splenic Infarction	4.9%
180	Histiocytosis, Langerhans-Cell	4.9%
181	Cryoglobulinemia	4.9%
182	Sarcoma 180	4.8%
183	Leukemia, Myelomonocytic, Chronic	4.8%
184	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	4.8%
185	Adenocarcinoma	4.8%
186	Carcinoma in Situ	4.8%
187	Carcinoma, Transitional Cell	4.8%
188	Phyllodes Tumor	4.8%
189	Dysgerminoma	4.8%
190	Hemangioendothelioma	4.8%
191	Lipoma	4.8%
192	Myoma	4.8%
193	Myxoma	4.8%
194	Neuroma	4.8%
195	Papilloma	4.8%
196	Pseudomyxoma Peritonei	4.8%
197	Seminoma	4.8%
198	Papillomatosis	4.8%
199	Angiolipoma	4.8%
200	Myelolipoma	4.8%
201	Neoplasms, Bone Tissue	4.8%
202	Neoplasms, Fibrous Tissue	4.8%
203	Smooth Muscle Tumor	4.8%
204	Adenomatosis, Pulmonary	4.8%
205	Adenomatous Polyps	4.8%
206	Carcinoma, Large Cell	4.8%
207	Carcinoma, Small Cell	4.8%
208	Desmoplastic Small Round Cell Tumor	4.8%
209	Chondroma	4.8%
210	Enchondroma	4.8%
211	Pheochromocytoma	4.8%
212	Alveolar rhabdomyosarcoma	4.8%
213	Glomerulonephritis, Membranoproliferative	4.7%
214	Carcinoid Heart Disease	4.7%
215	Mastocytosis	4.6%
216	Nephroblastoma	4.6%
217	Thrombocytopenic purpura	4.5%
218	Paraneoplastic Encephalomyelitis	4.4%
219	Mammary Neoplasms, Experimental	4.4%
220	Bone Marrow Neoplasms	4.3%
221	Autoimmune thrombocytopenia	4.3%
222	Immune thrombocytopenic purpura	4.3%
223	Basal Cell Nevus Syndrome	4.2%
224	Tuberous Sclerosis	4.2%
225	Splenic Rupture	4.2%
226	POEMS Syndrome	4.2%
227	Abdominal Neoplasms	4.1%
228	Erythroplasia	4.1%
229	Follicular cyst	4.1%
230	Head and Neck Neoplasms	4.1%
231	Mucocele	4.1%
232	Pilonidal Cyst	4.1%
233	Soft Tissue Neoplasms	4.1%
234	Thoracic Neoplasms	4.1%
235	Thyroglossal Cyst	4.1%
236	Synovial Cyst	4.1%
237	Aberrant Crypt Foci	4.1%
238	Disseminated Intravascular Coagulation	4.1%
239	Protein S Deficiency	4.1%
240	Hemangioma, Cavernous	4%
241	Acoustic Neuroma	4%
242	Carcinoma, Pancreatic Ductal	4%
243	Lymphopenia	3.9%
244	Mastocytosis, Systemic	3.8%
245	Transfusion-Related Acute Lung Injury	3.8%
246	Mesoblastic Nephroma	3.7%
247	Hepatocellular Adenoma	3.7%
248	Anemia	3.7%
249	Blood Coagulation Disorders	3.7%
250	Blood Platelet Disorders	3.7%
251	Bone Marrow Diseases	3.7%
252	Hemorrhagic Disorders	3.7%
253	Immune Complex Diseases	3.7%
254	Leukocyte Disorders	3.7%
255	Methemoglobinemia	3.7%
256	Pancytopenia	3.7%
257	Polycythemia	3.7%
258	Sulfhemoglobinemia	3.7%
259	Antiphospholipid Syndrome	3.7%
260	Thrombophilia	3.7%
261	Latex allergy	3.7%
262	Erythrocytosis	3.7%
263	Optic Nerve Glioma	3.6%
264	Lymphohistiocytosis, Hemophagocytic	3.6%
265	Schnitzler Syndrome	3.6%
266	Erdheim-Chester Disease	3.6%
267	Adenoid Cystic Carcinoma	3.6%
268	fibroma	3.6%
269	Fibromatosis	3.6%
270	Osteoblastoma	3.6%
271	Osteoma	3.6%
272	Rhabdomyoma	3.6%
273	Chondromatosis	3.6%
274	Adenocarcinoma, Clear Cell	3.6%
275	Cholangiocarcinoma	3.6%
276	Cervical Intraepithelial Neoplasia	3.6%
277	Hemangioblastoma	3.6%
278	Leukemia, Myeloid, Chronic-Phase	3.5%
279	Thrombocythemia, Essential	3.5%
280	Hydatidiform Mole	3.5%
281	Digestive System Neoplasms	3.4%
282	Endocrine Gland Neoplasms	3.4%
283	Eye Neoplasms	3.4%
284	Nervous System Neoplasms	3.4%
285	Vipoma	3.3%
286	Bone neoplasms	3.3%
287	Leukoplakia	3.3%
288	Pancreatic Cyst	3.3%
289	Skin Neoplasms	3.3%
290	Barrett Esophagus	3.3%
291	Breast Cyst	3.3%
292	Actinic keratosis	3.3%
293	Mediastinal Cyst	3.3%
294	Neoplasm Invasiveness	3.3%
295	Neoplasm Metastasis	3.3%
296	Neoplasm Recurrence, Local	3.3%
297	Parovarian Cyst	3.3%
298	Pericardial Cyst	3.3%
299	Thymic Cyst	3.3%
300	Carcinogenesis	3.3%
301	Myxoid cyst	3.3%
302	Metastasis	3.3%
303	Sturge-Weber Syndrome	3.3%
304	Multiple Endocrine Neoplasia Type 1	3.3%
305	Gastrointestinal Stromal Tumors	3.2%
306	Prolactinoma	3.2%
307	Growth Hormone-Secreting Pituitary Adenoma	3.2%
308	neurofibroma	3.2%
309	Environmental Illness	3.1%
310	Thrombasthenia	3%
311	Antithrombin III Deficiency	3%
312	Protein C Deficiency	3%
313	Lupus Erythematosus, Systemic	3%
314	Pregnancy Complications, Hematologic	3%
315	Overlap syndrome	3%
316	Fibromatosis, Aggressive	3%
317	Fibromatosis, Abdominal	3%
318	Klatskin Tumor	3%
319	Polycythemia Vera	3%
320	Addison Disease	3%
321	Pemphigus	3%
322	Autoimmune thyroiditis	3%
323	Primary Adrenal Insufficiency	3%
324	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	2.9%
325	Autoimmune hepatitis	2.9%
326	Mastocytoma	2.9%
327	Adenomatous Polyposis Coli	2.9%
328	Liver Neoplasms, Experimental	2.9%
329	Parathyroid Neoplasms	2.9%
330	Peritoneal Neoplasms	2.9%
331	Thyroid Neoplasm	2.9%
332	Thyroid carcinoma	2.9%
333	granulosa cell tumor	2.9%
334	Carcinoma, Ovarian Epithelial	2.9%
335	Lambert-Eaton Myasthenic Syndrome	2.7%
336	Corpus Luteum Cyst	2.7%
337	Ovarian Cysts	2.7%
338	Wiskott-Aldrich Syndrome	2.7%
339	Vitamin K Deficiency	2.7%
340	insulinoma	2.7%
341	Hydrops Fetalis	2.6%
342	Thrombocytosis	2.6%
343	Job Syndrome	2.6%
344	Kernicterus	2.6%
345	Afibrinogenemia	2.5%
346	Factor VII Deficiency	2.5%
347	Factor X Deficiency	2.5%
348	Factor XII Deficiency	2.5%
349	Hemophilia A	2.5%
350	Activated Protein C Resistance	2.5%
351	Factor II deficiency	2.5%
352	Factor VIII Deficiency	2.5%
353	Factor V deficiency	2.5%
354	Factor XI Deficiency	2.5%
355	Hypoprothrombinemias	2.5%
356	Pancreatic Neoplasm	2.5%
357	Latent Autoimmune Diabetes in Adults	2.5%
358	Dermatitis Herpetiformis	2.5%
359	Kounis Syndrome	2.5%
360	HIV Infections	2.5%
361	Eosinophilic Granuloma	2.4%
362	Splenosis	2.4%
363	Retroperitoneal Neoplasms	2.4%
364	Adrenocortical carcinoma	2.4%
365	Gastrinoma	2.4%
366	Glucagonoma	2.4%
367	Choledochal Cyst	2.4%
368	Tracheal Neoplasms	2.4%
369	Peutz-Jeghers Syndrome	2.3%
370	Leukoplakia, Oral	2.3%
371	Nasopharyngeal carcinoma	2.3%
372	Paraneoplastic Cerebellar Degeneration	2.3%
373	Leydig Cell Tumor	2.3%
374	Denys-Drash Syndrome	2.2%
375	Chronic granulomatous disease	2.2%
376	Rheumatoid Arthritis	2.1%
377	Juvenile arthritis	2.1%
378	Renal Cell Carcinoma	2.1%
379	Papillary Renal Cell Carcinoma	2.1%
380	Graves Disease	2.1%
381	Anti-Glomerular Basement Membrane Disease	2.1%
382	Asthma, Aspirin-Induced	2%
383	Dupuytren Contracture	2%
384	Esophageal Neoplasms	2%
385	Carcinoma, Endometrioid	2%
386	Limbic Encephalitis	2%
387	anaphylaxis	2%
388	Anemia, Hemolytic	2%
389	Anemia, Macrocytic	2%
390	Eosinophilia	2%
391	Food Allergy	2%
392	Hypoproteinemia	2%
393	Leukopenia	2%
394	Thrombocytopenia	2%
395	Leukostasis	2%
396	MYELODYSPLASTIC SYNDROME	2%
397	Anaphylactic shock	2%
398	Urticaria Pigmentosa	2%
399	Mouth Neoplasms	2%
400	Central Nervous System Neoplasms	2%
401	Vascular Neoplasms	2%
402	Genital Neoplasms, Female	1.9%
403	Pancreatic Pseudocyst	1.9%
404	Lymphatic Metastasis	1.9%
405	Neoplasms, Unknown Primary	1.9%
406	Leukemic Infiltration	1.9%
407	Breast Neoplasms, Male	1.9%
408	Neoplasm Micrometastasis	1.9%
409	Triple Negative Breast Neoplasms	1.9%
410	Hemoglobinuria, Paroxysmal	1.9%
411	Leukemoid Reaction	1.9%
412	Myelitis, Transverse	1.9%
413	Thyroid Nodule	1.9%
414	Serum Sickness	1.8%
415	Testicular Neoplasms	1.8%
416	Purpura, Thrombotic Thrombocytopenic	1.7%
417	Respiratory Hypersensitivity	1.7%
418	Adrenal Gland Neoplasms	1.7%
419	Gastrointestinal Neoplasms	1.7%
420	Genital Neoplasms, Male	1.7%
421	Liver neoplasms	1.7%
422	Uveal Neoplasms	1.7%
423	Urologic Neoplasms	1.6%
424	Anemia, Neonatal	1.6%
425	Leukocytosis	1.6%
426	Pelger-Huet Anomaly	1.6%
427	Sick Building Syndrome	1.6%
428	Pleocytosis	1.6%
429	Multiple Chemical Sensitivity	1.6%
430	Opsoclonus-Myoclonus Syndrome	1.6%
431	Sebaceous Gland Neoplasms	1.6%
432	Spinal Neoplasms	1.6%
433	Anemia, Sickle Cell	1.6%
434	Thalassemia	1.6%
435	Urticaria	1.6%
436	Vasculitis, Leukocytoclastic, Cutaneous	1.6%
437	HTLV-I Infections	1.6%
438	Polycystic Ovary Syndrome	1.6%
439	Anemia, Diamond-Blackfan	1.6%
440	Xeroderma Pigmentosum	1.5%
441	Ataxia Telangiectasia	1.5%
442	Myasthenia Gravis	1.4%
443	Uveomeningoencephalitic Syndrome	1.4%
444	Drug Eruptions	1.4%
445	Ecchymosis	1.4%
446	Petechiae	1.4%
447	Purpura	1.4%
448	Granulomatosis with polyangiitis	1.3%
449	Dermatitis, Allergic Contact	1.3%
450	HIV Seropositivity	1.3%
451	Nose Neoplasms	1.3%
452	Meningeal Neoplasms	1.3%
453	Palatal Neoplasms	1.3%
454	ovarian neoplasm	1.2%
455	Pituitary Adenoma	1.2%
456	Pituitary Neoplasms	1.2%
457	Purpura, Hyperglobulinemic	1.2%
458	Primary Myelofibrosis	1.2%
459	Agranulocytosis	1.2%
460	Anemia, Megaloblastic	1.2%
461	Lymphocytosis	1.2%
462	Myelofibrosis	1.2%
463	Myeloid Metaplasia	1.2%
464	Milk Allergy	1.2%
465	Hypoalbuminemia	1.2%
466	Wheat Hypersensitivity	1.2%
467	Hypereosinophilic syndrome	1.2%
468	bone marrow fibrosis	1.2%
469	Thrombotic Microangiopathies	1.2%
470	Stiff-Person Syndrome	1.2%
471	Polyradiculoneuropathy	1.2%
472	Polyradiculoneuritis	1.2%
473	Acquired Immunodeficiency Syndrome	1.2%
474	AIDS related complex	1.2%
475	Felty Syndrome	1.2%
476	Lupus Nephritis	1.2%
477	Hemolytic-Uremic Syndrome	1.1%
478	Ear Neoplasms	1.1%
479	Eyelid Neoplasms	1.1%
480	Lung Neoplasms	1.1%
481	Pleural Neoplasms	1.1%
482	Cell Transformation, Viral	1.1%
483	Brain Neoplasms	1.1%
484	Salivary Gland Neoplasms	1.1%
485	Spinal Cord Neoplasms	1.1%
486	Tongue Neoplasms	1.1%
487	Myasthenia Gravis, Autoimmune, Experimental	1.1%
488	Waterhouse-Friderichsen Syndrome	1.1%
489	Uterine Neoplasms	1.1%
490	Vaginal Neoplasms	1.1%
491	Vulvar Neoplasms	1.1%
492	Uterine Cancer	1.1%
493	Fallopian Tube Neoplasms	1.1%
494	AIDS-Related Opportunistic Infections	1%
495	Vasculitis, Central Nervous System	1%
496	Sickle Cell Trait	1%
497	Dermatitis, Atopic	1%
498	HIV Wasting Syndrome	1%
499	Rheumatoid Vasculitis	1%
500	AIDS Dementia Complex	1%
501	AIDS-Associated Nephropathy	1%
502	Zollinger-Ellison syndrome	1%
503	Meningeal Carcinomatosis	1%
504	Pharyngeal Neoplasms	1%
505	Central Nervous System Cysts	0.9%
506	Bile Duct Neoplasms	0.9%
507	gallbladder neoplasm	0.9%
508	Intestinal Neoplasms	0.9%
509	Penile Neoplasms	0.9%
510	Prostatic Neoplasms	0.9%
511	Stomach Neoplasms	0.9%
512	Lupus Vasculitis, Central Nervous System	0.9%
513	Fanconi Anemia	0.9%
514	Sicca Syndrome	0.9%
515	Sjogren's Syndrome	0.9%
516	HIV-Associated Lipodystrophy Syndrome	0.9%
517	Laryngeal neoplasm	0.8%
518	Eosinophilia-Myalgia Syndrome	0.8%
519	Acute Chest Syndrome	0.8%
520	Bronchial Neoplasms	0.8%
521	Angioedema	0.8%
522	Multiple Sclerosis	0.8%
523	Shwartzman Phenomenon	0.8%
524	Bladder Neoplasm	0.8%
525	Kidney Neoplasm	0.8%
526	Ureteral Neoplasms	0.8%
527	Urethral Neoplasms	0.8%
528	Multiple Pulmonary Nodules	0.8%
529	Scurvy	0.8%
530	Purpura Fulminans	0.8%
531	Acute Generalized Exanthematous Pustulosis	0.8%
532	Supratentorial Neoplasms	0.8%
533	Neutropenia	0.8%
534	Endometrial Neoplasms	0.8%
535	Atypical Hemolytic Uremic Syndrome	0.8%
536	Neuromyelitis Optica	0.7%
537	Leukoencephalitis, Acute Hemorrhagic	0.7%
538	Niemann-Pick Disease, Type C	0.7%
539	Asthma	0.7%
540	Hypopharyngeal Neoplasms	0.7%
541	Pleural Effusion, Malignant	0.7%
542	Hypopharyngeal Cancer	0.7%
543	Encephalomyelitis, Acute Disseminated	0.7%
544	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	0.7%
545	Erythema Nodosum	0.7%
546	Neuritis, Autoimmune, Experimental	0.7%
547	Dermatitis, Photoallergic	0.7%
548	Parotid Neoplasms	0.7%
549	Prostatic Neoplasms, Castration-Resistant	0.7%
550	Nelson Syndrome	0.7%
551	Brain Stem Neoplasms	0.7%
552	Pulmonary Eosinophilia	0.7%
553	Eosinophilic Pneumonia	0.7%
554	Anemia, Pernicious	0.6%
555	Aspergillosis, Allergic Bronchopulmonary	0.6%
556	Guillain-Barre Syndrome	0.6%
557	Cecal Neoplasms	0.6%
558	Duodenal Neoplasms	0.6%
559	Febrile Neutropenia	0.6%
560	Choroid Plexus Papilloma	0.6%
561	Tonsillar Neoplasms	0.6%
562	Cerebellar Neoplasms	0.6%
563	Nasopharyngeal Neoplasms	0.5%
564	Asthma, Exercise-Induced	0.5%
565	Status Asthmaticus	0.5%
566	Toxic Epidermal Necrolysis	0.5%
567	Stevens-Johnson Syndrome	0.5%
568	Colorectal Neoplasms	0.5%
569	Multiple Sclerosis, Chronic Progressive	0.5%
570	Multiple Sclerosis, Relapsing-Remitting	0.5%
571	Radicular Cyst	0.5%
572	Appendiceal Neoplasms	0.5%
573	Colonic Neoplasms	0.5%
574	Rectal Neoplasms	0.5%
575	Pseudoxanthoma Elasticum	0.5%
576	Paranasal Sinus Neoplasms	0.5%
577	Giant Cell Arteritis	0.5%
578	Temporal Arteritis	0.5%
579	Asthma, Occupational	0.5%
580	Farmer's Lung	0.5%
581	Angioedemas, Hereditary	0.5%
582	Hay fever	0.5%
583	Rhinitis, Allergic, Perennial	0.5%
584	Maxillary Sinus Neoplasms	0.4%
585	Hereditary Angioedema Type III	0.4%
586	Hereditary Angioedema Types I and II	0.4%
587	Anus Neoplasms	0.4%
588	Sigmoid Neoplasms	0.4%
589	Miller Fisher Syndrome	0.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234